Research case studies

All NHS organisations are expected to participate and support health and care research.

Conducting high-quality clinical research helps us to keep improving NHS care by finding out which treatments work best.

If you are asked about taking part in research, usually someone in the care team looking after you will contact you. People in your care team may look at your health records to check whether you are suitable to take part in a research study, before asking you whether you are interested or sending you a letter on behalf of the researcher.

For more information about how your information may be used in research and your rights please visit

Clinical research taking place in this practice has included focusing on health issues relating to Diabetes, Cancer, Cardiac & Stroke.

Examples and background information to current trails taking place  here at Stowhealth:-

Mclaren worked closely with Stowhealth and UCS in the Helping Health Change Project a study the impact of technology in managing obesity and weight related illness. For more information you can also visit the Mclaren website by clicking here

ARRIVE (Aspirin to Reduce Risk of Initial Vascular Events) is one of the largest clinical studies ever conducted in a population at moderate risk of initial events associated with cardiovascular and cerebrovascular disease (CVD). For more information go to

The Global Anticoagulant Registry in the FIELD (Garfield) is a prospective, multicentre, international registry of patients newly diagnosed with atrial fibrillation (AF). Garfield is an academic research initiative led by the Thrombosis Research Institute, London. It is designed to determine in real-life practice the management of newly-diagnosed patients with AF with at least one additional risk factor for stroke. From more information go to

Antibiotics are often prescribed to patients seeing their GP with a cough when the GP suspects the patient has a Lower Respiratory Tract Infection (LRTI; also known as a chest infection). Many patients are prescribed antibiotics because the GP does not have the tools to predict which people might develop complications (and may therefore benefit from antibiotics). The aim of this study is to determine if we can predict which patients seeing their GP with a cough and suspected LRTI will go onto develop severe complications, i.e. pneumonia that requires hospitalisation. For more information go to